Coatue Management Adds $34M in Novavax, Inc. ($NVAX)
Key Points
- $NVAX last traded around $8.88.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Coatue Management acquired a new position in Novavax, Inc. ($NVAX), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,836,986 shares of Novavax, Inc.. Coatue Management's holdings in Novavax, Inc. were worth $34.07 million as of its most recent filing.
Novavax, Inc. Stock Down 4.1%
Shares of Novavax, Inc. ($NVAX) traded around $8.88 on Saturday, down 4.1% for the day.
Novavax, Inc. Earnings
Analysts Set New Price Targets
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Get Novavax, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NVAX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.